DE2600814A1 - Tricyclische phloroglucinderivate - Google Patents

Tricyclische phloroglucinderivate

Info

Publication number
DE2600814A1
DE2600814A1 DE19762600814 DE2600814A DE2600814A1 DE 2600814 A1 DE2600814 A1 DE 2600814A1 DE 19762600814 DE19762600814 DE 19762600814 DE 2600814 A DE2600814 A DE 2600814A DE 2600814 A1 DE2600814 A1 DE 2600814A1
Authority
DE
Germany
Prior art keywords
dibenzo
pyran
tetrahydro
trimethyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762600814
Other languages
German (de)
English (en)
Inventor
Frederick Coulston
Friedrich Wilhelm August Korte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE2600814A1 publication Critical patent/DE2600814A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19762600814 1975-01-13 1976-01-12 Tricyclische phloroglucinderivate Pending DE2600814A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54073375A 1975-01-13 1975-01-13

Publications (1)

Publication Number Publication Date
DE2600814A1 true DE2600814A1 (de) 1976-07-15

Family

ID=24156703

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762600814 Pending DE2600814A1 (de) 1975-01-13 1976-01-12 Tricyclische phloroglucinderivate

Country Status (6)

Country Link
JP (1) JPS5195073A (ja)
AU (1) AU8763275A (ja)
CA (1) CA1082203A (ja)
DE (1) DE2600814A1 (ja)
GB (1) GB1510431A (ja)
SE (1) SE7600292L (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009099670A2 (en) * 2008-02-08 2009-08-13 Nektar Therapeutics Al, Corporation Oligomer-cannabinoid conjugates
US10780139B1 (en) 2020-03-19 2020-09-22 King Abdulaziz University Hypericum revolutum extract as a vasodilator

Also Published As

Publication number Publication date
SE7600292L (sv) 1976-07-14
AU8763275A (en) 1977-06-23
CA1082203A (en) 1980-07-22
JPS5195073A (ja) 1976-08-20
GB1510431A (en) 1978-05-10

Similar Documents

Publication Publication Date Title
DE2904552C2 (de) 2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarbonsäure-3-(1-benzylpyrrolidin-3-yl)ester-5-niedrigalkylester
DE2451417C3 (de) Ester der 6,-Dimethyl-4-hydroxymethyl- l-phthalazon-7-carbonsäure, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4321306A1 (de) Disulfide
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE2528609C3 (de) Desoxyvincaminsäureamide, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und Arzneimittel
DE2941288A1 (de) Cystein-derivate
DE2504045B2 (de) 16,17 dihydro-apovincaminsaeure-2- hydroxypropylester, deren salze, verfahren zu ihrer herstellung und arzneimittel
DE3721223C2 (ja)
DE2600814A1 (de) Tricyclische phloroglucinderivate
DE1965711C3 (de) l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2716172C2 (de) Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel
DE2336670A1 (de) Aminoaether von o-thymotinsaeureestern
EP0054873A1 (de) 3,4-Disubstituierte 1,2,5-Oxadiazol-2-oxide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2520131C3 (de) 1,1,-Disubstituierte Octahydro-indolo[2,3-a]chinolizine und verfahren zu deren Herstellung
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE1947226C3 (de) 1 l-Chlor-8,12b-dihydro-23-dimethyll2b-phenyl-4H [13] -oxazino [3,2-d] [1,4] benzodiazepin-4,7(6H)dion und Verfahren zur Herstellung dieser Verbindung
DE2632951A1 (de) Neue 1-deoxy-2,3-0-alkyliden-ribofuranuronsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69018741T2 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
DE1941933C3 (de) Basisch substituierte 10,11- Dihydro-5,10-endoxa-SH-dibenzo- [a,d] -cycloheptene und deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD141927A5 (de) Verfahren zur herstellung von 1,1-disubstituierten octahydroindolo eckige klammer auf 2,3-a eckige klammer zu chinolizinen
DE2914805A1 (de) Tetrahydroalstoninderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT339911B (de) Verfahren zur herstellung eines neuen 1-phthalazonderivates
DE2834911C2 (de) Antihypertonikum
DE2541485C3 (de) 1-Alkyl-1-(2-cyanäthyl)-1,2,3,4,6,7-hexahydroindolo- [2,3-a] chinolizinderivate